chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a registered nurse for the pregnancy registry for GARDASIL concerning a 17 years old female patient with no pertinent medical history and no known drug allergies/drug reactions who in June 2008 was vaccinated with the second dose of GARDASIL. There was no concomitant medication. It was reported that the patient had not received the third dose and it has been determined to be pregnant. it was reported that on 02-FEB-2009 a prenatal ultrasound was performed and it revealed a normal pregnancy. Last menstrual period was approximately 16-JUN-2008 and the estimated delivery date was on 25-MAR-2009. The patient sought medical attention with a office visit. Follow up information from a registered nurse concerning the patient with a history of Chlamydia and no concurrent medical conditions who in June 2008 was vaccinated with the second dose of GARDASIL (lot # unknown). Date of last menstrual period was 18-JUN-2008 and estimated conception date unknown. The estimated delivery date was 25-MAR-2009. Follow up information from a registered nurse concerning the female patient who on 16-MAR-2009 delivered a normal male baby without congenital anomalies weighting 2945 gm, apgar score 6/7 (38 6/7 weeks from LMP). Complications during delivery included nuchal cord x1 (tight), and resuscitation was performed at delivery and the baby was admitted to the special care nursery for grunting. During pregnancy there were no complications, infections or illnesses, and no diagnostic tests were performed. Upon internal review, nuchal cord x1 (tight) requiring resuscitation was determined to be an other important medical event. Additional information has been requested.
Information has been received from a nurse referring to a patient of unknown age and gender. The patient's medical history, concurrent condition and concomitant therapy were not reported. On 07-AUG-2017,  the patient was vaccinated with a dose of improperly stored VAQTA (strength, dose, frequency and route unknown, lot # N005605, expiration date 08-APR-2018). The vaccine was stored at 47 to 77 degrees Fahrenheit for 15 minutes. There was no previous temperature excursion and the phone call was a result of the data logger. No adverse effects were reported.
This spontaneous report was received from a medical assistant referring to a multiple unspecified patients of unknown age and gender. No information regarding the patients' medical history, concurrent conditions or concomitant therapies was provided. On an unknown date, the patients were vaccinated with improperly stored doses of GARDASIL 9 (strength, dose number, route, anatomical location, lot number and expiration date were not provided) for prophylaxis. No adverse events reported. No product quality complaint was involved. The vaccines were improperly stored with a temperature of excursion of: 32-36°F (Fahrenheit degrees) for 8 hours and 12 hours respectively. There were no previous temperature excursion. This is one of several reports received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1702USA002890: US-009507513-1702USA005003: US-009507513-1702USA005001:
Began having headache 3hrs after injection, nausea, dizziness,  generalized aching began approx. 4 hours post injection, worsening  throughout afternoon  and evening, low grade fever - 99.4,  unable to eat or sleep through next am with symptoms decreasing  during day after injection. Resolved 48 hours post injection.  Extra Strength Acetaminophen decreased discomfort slightly.
upper stomach pain; cramping feeling; extreme nausea; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (upper stomach pain), MUSCLE SPASMS (cramping feeling) and NAUSEA (extreme nausea) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ABDOMINAL PAIN UPPER (upper stomach pain), MUSCLE SPASMS (cramping feeling) and NAUSEA (extreme nausea). At the time of the report, ABDOMINAL PAIN UPPER (upper stomach pain), MUSCLE SPASMS (cramping feeling) and NAUSEA (extreme nausea) outcome was unknown.            No concomitant medications were reported. No treatment was reported.  Action taken with mRNA-1273 in response to the event was not applicable.
This spontaneous report was received from an office manager referring to a patient of unknown age and gender. On 05-JUL-2017, the patient was vaccinated with a dose of GARDASIL lot # M014929 expiration date: 27-MAY-2017 for prophylaxis. On 05-JUL-2017, the patient experienced expired product administered. On an unknown date the patient experienced no adverse event. The outcome of expired product administered and no adverse event was unknown. The reporter considered expired product administered and no adverse event to be not related to GARDASIL.
1242- Pt stated that she was starting to feel a little itchy in her throat. She said she pre-medicated with 25mg benadryl because of an itchy throat after previous dose. I walked her to EMS area. They hooked her up to BP and pulse ox while I went to get another benadryl. 1244 benadryl 25mg PO given to pt. She stated that it was difficult to swallow. VS-HR134, 100%, 124/91; 1248 Epi 0.3 in R deltiod by EMS. IV unsuccessful attempt by EMS. 1255 VS HR 118, 98%, 141/87. 1258 Transported by EMS.
Pt administered 1st dose ROTATEQ, had projectile vomiting with copious emesis from mouth +nostrils. No other vaccine had been given. Pt observed and no other S/S presented + vomiting stopped
Rashes around the injection site, irritation and itchy, symptoms began on Tuesday 9/20/2022.
fever; Pain at injection site; Headache; Runny nose; itchy eyes; Body aches; Swollen glands; This is a spontaneous report from a contactable consumer (patient). A 55-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Lot number: unknown), via an unspecified route of administration, administered in Arm Left on 02Mar2021 at 16:00 (at the age of 55-years-old) as single dose for COVID-19 immunization. The patient had no relevant medical history. The patient had no known allergies. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive other vaccines in 2 weeks. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient was not pregnant at the time of vaccination. On 03Mar2021 at 07:00, the patient experienced pain at injection site, headache, runny nose and itchy eyes, body aches, swollen glands. On 07Mar2021 at 07:00, after day 6, the patient started running a 102 fever. Adverse events resulted in doctor or other healthcare professional office or clinic visit. Post vaccination, the patient had been tested for COVID-19. The patient underwent lab tests and procedures which included Fever: 102 on 07Mar2021, Nasal swab test on 09Mar2021: Result pending. The clinical outcome of the events was not resolved.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Never got the second one; This case was reported by a consumer via media and described the occurrence of incomplete course of vaccination in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included shingles vaccine (received in October 2017, it was just one shot), shingles vaccine with an associated reaction of adverse drug reaction (received 1st shot in June 2019) and flu shot with an associated reaction of adverse drug reaction (received on an unknown date, refer case id: US2021AMR100337).   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows:  The patient had reported the case for himself/herself. The age at vaccination was not applicable. The age group was not reported but was captured as an adult as per vaccine indication.  The patient had a reaction to 1st Shingles shot and till the time of reporting he/she never got the second one, which led to incomplete course of vaccination. The reporter reported he/she just very unlucky with shots had same thing happened with the flu shot.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR100337:Same reporter.
Diagnosed with myocarditis 2 days after second Pfizer COVID-19 vaccination. Presented with chest pain and palpitations.
Patient felt unwell after vaccination. He stated feeling light headed,  dizzy and knees shaky.  He also stated his whole arm hurt.  He sat for 30 minutes after vaccination and was feeling better.   He did state his arm still hurt.  We gave him water and and ice pack.  I called the parents again 1.5 hours later and they stated he is feeling okay
day p/vax pt devel temp 105, limp, rash on stomach, back. taken to urgent care didn't have a physician @ the time;
On August 24, I developed gross hematuria and sought medical care. On September 2, I was diagnosed with bladder cancer. A small (<2cm) papillary urothelial carcinoma was surgically removed from my bladder, and I was treated with a 1 hour instillation of 120 ml of gencitibine following surgery.
Fist size itchy rash on arm (injection site) that presented approx a week after injection. Has persisted until current. No medical treatment other than topical ointment to suppress itching. May contact doctor just for reporting purposes.
Patient received the Pfizer COVID-19 vaccine on 1/27/21 and 2/19/21 so was fully vaccinated when they tested positive for COVID-19 on 9/1/21.
Swollen lymph nodes, sore left breast, tingling down left arm, tingling in left leg.  Vaccine administered to left arm.  Symptoms started about 2 weeks after receiving 2nd vaccine.  2 weeks after symptoms started the symptoms are not as severe but still have symptoms, 4/4/2021, a month after 2nd dose.  Have not contacted my doctor yet.
hearing loss; zoster-related conditions; Information has been received regarding a case in litigation, from a lawyer, concerning a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported.     On 01-JAN-2015, the patient was vaccinated with zoster vaccine live(ZOSTAVAX), for the long-term prevention of shingles and zoster-related conditions (prophylaxis) (strength, anatomical location, dose, route of administration, lot # and expiration date were not provided). On an unknown date, the patient experienced hearing loss and other zoster-related conditions. On an unknown date, the patient was treated by a health care provider for hearing loss and other zoster-related conditions. As a direct and proximate result of patient's use of the zoster vaccine live(ZOSTAVAX) vaccine, patient had and would continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization (on unspecified dates), physician care, monitoring, treatment, medications, and supplies. At the time of report, the patient was not recovered from hearing loss and other zoster-related conditions. The reporter considered the adverse events to be related to Zoster Vaccine Live(ZOSTAVAX).  Upon internal review, the hearing loss was considered as medically significant event.
Four days post vaccination; swelling w/ edema & erythema to left axillary region. No lesion present at time of visit.
Sudden chest tightening lasted 45 min. Throat closing off/on. Tightening/pain around my ribs. Nausea.
The day after receiving vaccines, arm was red and swollen and felt nauseous, "sick" for 1 week.
This spontaneous prospective pregnancy report was received from a female patient of unknown age and refers to herself. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided.  The patient reported, that she was 2 weeks pregnant at the time of the report (last menstrual period (LMP) was calculated as 09-JAN-2017, with estimated delivery date of 16-OCT-2017. On 16-JAN-2017, she was vaccinated with a dose of VARIVAX (route of administration, lot# and expiration date were not provided). The patient sought medical attention by speaking to physician. The pregnancy outcome was pending. Additional information has been requested.
This vaccination caused a blood clot in the brain, that, in turn, caused patient to have two(2) major strokes. Was admitted to Hospital as in patient for three (3) weeks
The patient received third booster dose of BNT162b2; Fever; Chills; Headache; Bodyaches; Pain under my arm; This is a spontaneous report from a non-contactable consumer, the patient. A 47-year-old non-pregnant female patient received third (booster) dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 08Nov2021 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not receive any concomitant medications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 29Mar2021 (at the age of 47-years-old) and also received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 19Apr2021 (at the age of 47-years-old) as a single dose for COVID-19 immunisation and had no side effects with both the doses. On 08Nov2021, with the third dose, the patient experienced fever, chills, headache, body aches and pain under the arm. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, chills, headache, body aches and pain under the arm were resolving at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
pt in a SNF; pt had a positive COVID test on 1/9/22 in the facility; treated with ABX; O2 via NC; pt passed away in the facility
pt recv 2 doses of vax & lab eval revealed a lack of seroconversion;
t103.7 mom sponged pt to dec temp; 1MAY95 t103 taken to PMD; rx Cefzol, Motrin & APAP; coughing, runny nose;
10/24 SEEN IN ER WITH DIFFICULTY BREATHING ONSET 1 WEEK. CHEST PAIN POST FALL DX: PNEUMONIA DUE TO COVID19, RESP FAILURE. HYPOXIC REQUIREING 5-6 L OF OXYGEN SATTING AT 92%. CONDITION CONTINUED TO DECLINE REQUIRING BIPAP THERAPY. PT AND FAMILY ELECTED TO TRANSITION TO COMFORT CARE. PATIENT DIED ON 11/4/21. PATIENT REC'D PFIZER COVID 19 VACCINATIONS: 3/1/21 AT HOSPITAL PFIZER LOT NUMBER : EL9269 DOSE 1 3/22/21 AT HOSPITAL PFIZER LOT NUMBER: EN6200 DOSE 2
The next day following the vaccine, I experienced muscle aches, headache,  fatigue, febrile temp before taking antifebrile medication at 100.8 F. At the site of injection on my left arm there was a red mark and slight swelling, left arm felt weak and sore. Overall sense of unwell lasted for two days.
Anaphylaxis, bronchospasm Narrative: was given EPI, steriods, albuterol oxygen, IV fluids, benadryl. Went to another ER 1/11 for new diastolic HTN, heart palpitations, bronchiolitis right lung. covid test negative. back pain and sob. given prednisone, epi, told to continue benadryl prn.
First regular menstrual cycle after booster shot - heavy flow (much more than usual), persistent cramps (much worse than usual), temperature fluctuations (woke up sweating in a 65 degree room after kicking off all blankets). Not menopausal, or premenopausal. Cycles are usually very predictable and mild, this is extremely unusual for me. Still only in first day of cycle.
Sore throat within first 24 hours, with mild stomach pain and muscle pain.  Slight headache.  No fever noticed.   Next 24 hours lungs become congested, along with hoarseness and dry cough.  Feeling of weakness and fatigue. Next 24 hours breathing becomes difficult with wheezing and coughing spasms.  Very fatigued and weak.  Headache worsens. Next 24 hours difficulty breathing, wheezing, and heavy non-productive coughing.  Skin pale, feeling dizzy and weak.  Patient taken to ER 1/26/05.
Starting on 9/1/18, 2 days after injections, I woke up to find patient not breathing. I had to shake her a few times for her to take a breath. This happened a few times that night and again several times in various different nights. The episodes lessened as time went on. It has been 6 months and she hasn't had anymore episodes.
Noted onset of headache before leaving the vaccination observation area. Headache located at back of head, with no accompanying symptoms, and later responded to Acetaminophen. Later, on the evening of vaccine receipt, patient felt sweaty and clammy and experienced chills and shaking; did not have a thermometer to check temperature; these symptoms did not interfere with sleep and were gone upon awakening on 6 Apr. Also, on night of vaccine receipt, patient felt fatigued and a little lightheaded, especially with movement; no worsening of symptoms on 6 Apr,  but symptoms had not resolved. Also, reports experiencing diarrhea which started afternoon of 5 Apr (> 4 hours post vaccination); of note, patient reports that she experiences diarrhea each year after receipt of IIV;  usually takes 1 or 2 doses of Imodium and typically does not last more than 24 to 48 hours.  Denied symptoms c/w immediate allergic reaction within 4 hours of vaccine receipt-no hives/itching/angioedema, no dizziness/disorientation/LOC, no shortness of breath/wheezing/bronchospasm, no increased heart rate/BP, no N/V/adb cramps. No significant local reaction around vaccination site on left upper arm; no swollen or tender axillary lymph nodes .   On 8 Apr, patient report "things back to normal"
on 7/16/21 3 days after the COVID vaccine patient started experiencing chest pain.
A nurse reported that an 18 year old male experienced diarrhea after receiving an injection of hepatitis B vaccine recombinant (Engerix B). The vaccine provided submitted a report to the state department of health. The subject's medical history included celiac sprue and allergies to chocolate and nuts. The subject experienced no adverse events following previous immunization. No concurrent medications were reported. On 7/22/02, the subject received his first injection of Engerix B. On the same date, he received injections of tetanus and diphtheria toxoids and MMR virus vaccine. Later that evening, the subject experienced diarrhea. The subject's mother called the physician's office and reported that the subject was also dehydrated and that she was giving him fluids. Additional information was received on 12/17/02. On 7/29/02, the subject was evaluated by an unspecified specialist and was treated with unspecified steroids. On 8/6/02, the mother stated that the subject was doing much better. The nurse reported that there was no complications. The nurse stated that the diarrhea and dehydration were possibly related to Engerix B administration and possibly related to celiac disease. The Engerix B immunization series was discontinued. As of 12/17/02, the events had resolved. The nurse indicated that the events jeopardized the subject or required intervention; therefore, this report has been reclassified as serious.
headache/Since the 2nd dose, it seems like I have a recurrent headache; I had a tremendous breakdown & pain in all of my joints/All of my joints are in tremendous pain/Both knees at same time went bad/It started with knees, then soon after it was my ankles, now wrists, & hips; It started with knees, then soon after it was my ankles, now wrists, hands, & hips; This spontaneous case was reported by an other health care professional and describes the occurrence of HEADACHE (headache/Since the 2nd dose, it seems like I have a recurrent headache), ARTHRALGIA (I had a tremendous breakdown & pain in all of my joints/All of my joints are in tremendous pain/Both knees at same time went bad/It started with knees, then soon after it was my ankles, now wrists, & hips) and PAIN IN EXTREMITY (It started with knees, then soon after it was my ankles, now wrists, hands, & hips) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (My oxygen reached 20%. I was in the hospital from 05Jan2021 through 13 JAN 2021) in January 2020 and Limb hyperextension.    On 28-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-May-2021, the patient experienced HEADACHE (headache/Since the 2nd dose, it seems like I have a recurrent headache), ARTHRALGIA (I had a tremendous breakdown & pain in all of my joints/All of my joints are in tremendous pain/Both knees at same time went bad/It started with knees, then soon after it was my ankles, now wrists, & hips) and PAIN IN EXTREMITY (It started with knees, then soon after it was my ankles, now wrists, hands, & hips). The patient was treated with PARACETAMOL (NON ASPIRIN) for Adverse event, at an unspecified dose and frequency. At the time of the report, HEADACHE (headache/Since the 2nd dose, it seems like I have a recurrent headache), ARTHRALGIA (I had a tremendous breakdown & pain in all of my joints/All of my joints are in tremendous pain/Both knees at same time went bad/It started with knees, then soon after it was my ankles, now wrists, & hips) and PAIN IN EXTREMITY (It started with knees, then soon after it was my ankles, now wrists, hands, & hips) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   There's a PKD (Polycystic kidney disease) History in family, but the patient remain negative. Concomitant medications were not reported. On 15-May-2021, the patient had a headache, tremendous breakdown and pain in all of my joints. Both knees at same time went bad. All of my joints are in tremendous pain. It started with knees, then soon after it was my ankles, now wrists, hands, & hips. Since the 2nd dose, it seems like I have a recurrent headache.  The took non aspirin regularly.   This case was linked to MOD-2021-413812 (Patient Link).
Itching, red rashes in armpits, neck, upper thighs, abdomen. patient took Benadryl and applied topical cortisone.
Lump pain redness in 1 hour numbness pain persist 10/21/13.
Approximately one hour after receiving flu vaccine, patient returns to clinic c/o, not feeling well", nausea, tingling fingertips and lips. At that time denies SOB/difficulty breathing. Soon began experiencing "itchy throat". Assessed by doctor. Released home with Rx for oral BENADRYL.